TrialThe oncologist2020

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy.

Lee Schwartzberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.